Showing results (1-10 of 416) with videos related to
Sort By:
Pageof 42
Cell Death and Differentiation|March 25, 2022
Should mutant TP53 be targeted for cancer therapy?Zilu Wang, Andreas Strasser, Gemma L KellyJournal of Molecular Cell Biology|November 30, 2018
Discussion of some 'knowns' and some 'unknowns' about the tumour suppressor p53Elizabeth Lieschke, Zilu Wang, Gemma L Kelly, et al.Cell Death and Differentiation|March 10, 2022
Flow cytometric single cell-based assay to simultaneously detect cell death, cell cycling, DNA content and cell senescenceElizabeth Lieschke, Zilu Wang, Catherine Chang, et al.Advances in Cancer Research|June 28, 2011
The essential role of evasion from cell death in cancerGemma L Kelly, Andreas StrasserCell Death and Differentiation|February 9, 2023
Lymphoma cells lacking pro-apoptotic BAX are highly resistant to BH3-mimetics targeting pro-survival MCL-1 but retain sensitivity to conventional DNA-damaging drugsSarah T Diepstraten, Savannah Young, John E La Marca, et al.Cell Death and Differentiation|April 9, 2022
Of the many cellular responses activated by TP53, which ones are critical for tumour suppression?Annabella F Thomas, Gemma L Kelly, Andreas StrasserCold Spring Harbor Perspectives in Medicine|May 4, 2016
Tumor-Suppressor Functions of the TP53 PathwayBrandon J Aubrey, Andreas Strasser, Gemma L KellyApoptosis : an International Journal on Programmed Cell Death|November 7, 2022
BCL-2 protein family: attractive targets for cancer therapyDeeksha Kaloni, Sarah T Diepstraten, Andreas Strasser, et al.Developmental Cell|October 8, 2024
Don't fear the reaper: The role of regulated cell death in tumorigenesis and BH3-mimetics for cancer therapyJohn E La Marca, Gemma L Kelly, Andreas Strasser, et al.Cell Death and Differentiation|November 18, 2017
How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression?Brandon J Aubrey, Gemma L Kelly, Ana Janic, et al.Pageof 42